COVID-19 UPDATES

Overlake arthritis and osteoporosis center – COVID-19 Vaccine Response

To our dear patients,

We understand there are questions you may have about the COVID-19 vaccine.

At this time, the Overlake Arthritis and Osteoporosis Center does not currently have the vaccine, due to the extreme temperatures required to store it. We also do not have a waitlist to administer the vaccine.

We are currently recommending that all our patients get the vaccine when you have access to it. This is consistent with the message from the American college of rheumatology. (ACR)

Comprehensive safety checks are required as part of the process leading to FDA approval of the vaccine.

We are providing a summary of our recommendations here:

After a detailed and thorough review of the data on the currently available vaccines. The two COVID-19 vaccines that have received FDA Emergency Use Authorization and approval from the Western States Scientific Review Group, we are reporting the following:

One vaccine was developed by Pfizer-BioNTech and the other by Moderna.

  • Both the Moderna and Pfizer vaccines are equally safe and effective.
  • The risk of the COVID-19 infection appears to be much higher than the risk of taking a vaccine.
  • There are many benefits of getting vaccinated for COVID-19 and doing so will help end the pandemic.
  • We still need to wear masks, practice physical distancing, and wash our hands to prevent the spread of the coronavirus.

Special cases:

For patients on Methotrexate, we have recommended you stop Methotrexate for 2 weeks after the vaccine, as this will allow an appropriate full response to the vaccine.

For patients on Rituximab, discuss with your Rheumatologist Dr. Dada or Dr. Ta the appropriate time of dosing Rituxan relative to the time of vaccination.

If there is a vaccine that we can safely administer to our patients and we are able to offer this vaccine, we will inform you.

We are all in this together,

Overlake Arthritis and Osteoporosis center.

Groups who should be offered vaccination next (1b and 1c)

CDC recommends that in Phase 1b and Phase 1c, which may overlap, vaccination should be offered to people in the following groups. CDC made this recommendation on December 22, 2020.

Phase 1b

  • Frontline essential workers such as fire fighters, police officers, corrections officers, food and agricultural workers, United States Postal Service workers, manufacturing workers, grocery store workers, public transit workers, and those who work in the educational sector (teachers, support staff, and daycare workers.)
  • People aged 75 years and older because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 75 years and older who are also residents of long-term care facilities should be offered vaccination in Phase 1a.

Phase 1c

  • People aged 65—74 years because they are at high risk of hospitalization, illness, and death from COVID-19. People aged 65—74 years who are also residents of long-term care facilities should be offered vaccination in Phase 1a.
  • People aged 16—64 years with underlying medical conditions which increase the risk of serious, life-threatening complications from COVID-19.
  • Other essential workers, such as people who work in transportation and logistics, food service, housing construction and finance, information technology, communications, energy, law, media, public safety, and public health.